NCT02585713 2020-08-04
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
Phase 3 Completed
Academic and Community Cancer Research United
University of Vermont
Janssen Research & Development, LLC
Beth Israel Deaconess Medical Center
Altor BioScience